Monitoring of bivalirudin anticoagulation during and after cardiopulmonary bypass using an ecarin-activated TEG system.
Koster
Andreas
A
Department of Anesthesia, Deutsches Herzzentrum, Berlin, Germany. koster@dhzb.de
Buz
Semih
S
Krabatsch
Thomas
T
Dehmel
Frank
F
Hetzer
Roland
R
Kuppe
Herman
H
Dyke
Cornelius
C
D000925:Anticoagulants / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects*; D002315:Cardiopulmonary Bypass; D016903:Drug Monitoring; D010450:Endopeptidases / Q000494:pharmacology*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006629:Hirudins / Q000493:pharmacokinetics*; D006801:Humans; D066298:In Vitro Techniques; D010446:Peptide Fragments / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000493:pharmacokinetics / Q000627:therapeutic use; D013916:Thrombelastography; D014914:Whole Blood Coagulation Time
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; D010450:Endopeptidases; C020097:ecarin; C074619:bivalirudin